CD274 and neoplasm: The patient tested positive for PD-L1 (TPS=18.11%, IPS<1%, tested using a Ventana SP263 assay), with a tumor mutation burden (TMB) of 3.7muts/Mb and microsatellite instability-low (MSI-L) status (35.29% unstable loci) (Supplementary Material 3).